MARKET

BAX

BAX

Baxter Intl
NYSE

Real-time Quotes | Nasdaq Last Sale

90.58
-0.53
-0.58%
Opening 13:50 01/24 EST
OPEN
91.23
PREV CLOSE
91.10
HIGH
91.47
LOW
90.55
VOLUME
1.01M
TURNOVER
--
52 WEEK HIGH
91.87
52 WEEK LOW
69.38
MARKET CAP
46.24B
P/E (TTM)
34.66
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BAX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BAX News

  • FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Baxter International Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  • ACCESSWIRE.1h ago
  • FINAL DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Reminds Baxter International Inc. Investors of Important January 24th Deadline in Securities Class Action
  • Business Wire.2h ago
  • BAXTER DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Baxter International Inc. - BAX
  • GlobeNewswire.6h ago
  • DEADLINE ALERT - Baxter International Inc. (BAX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: January 24, 2020
  • GlobeNewswire.1d ago

More

Industry

Medical Equipment, Supplies & Distribution
-0.80%
Healthcare Equipment & Supplies
-0.94%

Hot Stocks

Name
Price
%Change

About BAX

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.
More

Webull offers Baxter International Inc (BAX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.